Importantly, in Tg2576 mice, the most frequently used APP transgenic mouse model during first decade of AD immunotherapy studies, as well as in other commonly used Tg mice, pyroglutamate-modified Aβ peptides were not detected at all or detected in old animals at levels far lower than in human AD brain [27, 57, 58]. This evidence concerns the gene APP and Alzheimer disease.